BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37819699)

  • 21. Introduction of Microwave Ablation Into a Renal Ablation Practice: Valuable Lessons Learned.
    Thompson SM; Schmitz JJ; Thompson RH; Weisbrod AJ; Welch BT; Viers BR; Hannon JD; Schmit GD; Atwell TD; Kurup AN
    AJR Am J Roentgenol; 2018 Dec; 211(6):1381-1389. PubMed ID: 30247980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
    Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
    Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local recurrence and other oncologic outcomes after percutaneous image-guided tumor ablations on stageT1b renal cell carcinoma: a systematic review and network meta-analysis.
    Cazalas G; Jambon E; Coussy A; Le Bras Y; Petitpierre F; Berhnard JC; Grenier N; Marcelin C
    Int J Hyperthermia; 2021; 38(1):1295-1303. PubMed ID: 34461802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up.
    Castle SM; Salas N; Leveillee RJ
    Urology; 2011 Apr; 77(4):792-7. PubMed ID: 21324512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma.
    Yu J; Zhang G; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Li QY; Mu MJ; Li X
    Abdom Imaging; 2015 Oct; 40(8):3248-56. PubMed ID: 26288264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: evaluating the performance of nephrometry scores.
    Efthymiou E; Velonakis G; Charalampopoulos G; Mazioti A; Brountzos E; Kelekis N; Filippiadis D
    Eur Radiol; 2023 Nov; 33(11):7388-7397. PubMed ID: 37318604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.
    Shakeri S; Afshari Mirak S; Mohammadian Bajgiran A; Pantuck A; Sisk A; Ahuja P; Lu DS; Raman SS
    Abdom Radiol (NY); 2019 Jun; 44(6):2308-2315. PubMed ID: 30847565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of CT-guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney.
    Meng H; Yang H; Jia H; Pan F; Dong X; Liu B; Li C
    Int J Hyperthermia; 2021; 38(1):691-695. PubMed ID: 33899668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous Microwave Ablation of Category T1a Renal Cell Carcinoma: Intermediate Results on Safety, Technical Feasibility, and Clinical Outcomes of 119 Tumors.
    Guo J; Arellano RS
    AJR Am J Roentgenol; 2021 Jan; 216(1):117-124. PubMed ID: 32603227
    [No Abstract]   [Full Text] [Related]  

  • 32. Ultrasound-guided hydrodissection for assisting percutaneous microwave ablation of renal cell carcinomas adjacent to intestinal tracts: a preliminary clinical study.
    Cheng Z; Yu X; Han Z; Liu F; Yu J; Liang P
    Int J Hyperthermia; 2018 May; 34(3):315-320. PubMed ID: 28641464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results.
    Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Mu MJ; Wang XH
    Radiology; 2012 Jun; 263(3):900-8. PubMed ID: 22495684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced CT immediately following percutaneous microwave ablation of cT1a renal cell carcinoma: Optimizing cancer outcomes.
    Koebe SD; Curci NE; Caoili EM; Triche BL; Dreyfuss LD; Allen GO; Brace CL; Davenport MS; Abel EJ; Wells SA
    Abdom Radiol (NY); 2022 Aug; 47(8):2674-2680. PubMed ID: 35278110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation.
    Moreland AJ; Ziemlewicz TJ; Best SL; Hinshaw JL; Lubner MG; Alexander ML; Brace CL; Kitchin DR; Hedican SP; Nakada SY; Lee FT; Abel EJ
    J Endourol; 2014 Sep; 28(9):1046-52. PubMed ID: 24846329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous microwave ablation of renal cell carcinoma using a high power microwave system: focus upon safety and efficacy.
    Filippiadis DK; Gkizas C; Chrysofos M; Siatelis A; Velonakis G; Alexopoulou E; Kelekis A; Brountzos E; Kelekis N
    Int J Hyperthermia; 2018 Nov; 34(7):1077-1081. PubMed ID: 29202667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous Microwave Ablation Versus Cryoablation in the Treatment of T1a Renal Tumors.
    De Cobelli F; Papa M; Panzeri M; Colombo M; Steidler S; Ambrosi A; Cao R; Gusmini S; Marra P; Capitanio U; Bertini R; Venturini M; Losa A; Gaboardi F; Montorsi F; Cardone G
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):76-83. PubMed ID: 31451888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of MWA versus RFA and CA for renal tumors: A systematic review and meta-analysis of comparison studies.
    Castellana R; Natrella M; Fanelli G; Lancellotta V; Cornacchione P; Castellana M; Filippiadis D; Tagliaferri L; Iezzi R
    Eur J Radiol; 2023 Aug; 165():110943. PubMed ID: 37392547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.